Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
As diabetes drives up Kentuckians use of weight-loss drugs, worries arise about unintended effects Louisville researchers are looking at GLP-1 medicines possible role in eating disorders Ruth Taylor, left, and Benjamin Knoll are among the many Kentuckians who have tried prescription weight loss drugs
Whether youre a prescriber, pharmacist or patient, the message is clear: Personalized care, open communication and compliance are the keys to success
An important distinction from the FDA criteria is that the WHO guideline does not extend its recommendation to adults with a BMI between 27 and 30 who have obesity-related conditions
They are recommended for those who are overweight or obese and have not achieved optimal glycemic control despite intensive insulin therapy
Seufert J, Gallwitz B (2014) The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems
